Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Levocetirizine | Levocetirizine ((R)-Cetirizine) is a third-generation peripheral H1-receptor antagonist. Levocetirizine is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: (R)-Cetirizine. CAS No. 130018-77-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0814. |  |
| Levocetirizine | . Uses: Histamine h1 antagonists, non-sedating. Synonyms: (2-(4-((R)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride; (2-(4-((R)-p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid; cetirizine (R)-form dihydrochloride. Grades: 98%. CAS No. 130018-77-8. Molecular formula: C21H25ClN2O3. Mole weight: 388.89. |  |
| Levocetirizine dihydrochloride | Levocetirizine dihydrochloride. Group: Biochemicals. Alternative Names: (R)-Cetirizine dihydrochloride. Grades: Highly Purified. CAS No. 130018-77-8. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C21H27Cl3N2O3. US Biological Life Sciences. |  Worldwide |
| Levocetirizine dihydrochloride | Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: (R)-Cetirizine dihydrochloride. CAS No. 130018-87-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-W010841. | |
| Levocetirizine Dihydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: Levocetirizine dihydrochloride, Allercet, (R)-Cetirizine dihydrochloride, Allear, Xyzall, Xyzal,Levocetirizine Dihydrochloride, Lezyncet, (R)-(-)-Cetirizine hydrochloride, Xusal, Acetic acid, [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride, (R)-, Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2), Acetic acid, [2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride (9CI), UCB 28556. |  |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride. CAS No. 130018-87-0. Product ID: 1-01726. Molecular formula: C21H27Cl3N2O3. Mole weight: 461.82. |  |
| Levocetirizine Impurity 1 | Grades: > 95%. Molecular formula: C28H32ClN3O2. Mole weight: 478.04. | |
| Levocetirizine Impurity 11 | Levocetirizine Impurity 11 is one of Levocetirizine impurities. Levocetirizine is an antihistamine used routinely for the treatment of various allergic disorders such as urticaria, eczemas, and also in itchy lesions of skin like scabies. Synonyms: 2-(2-(1-(2-(carboxymethoxy)ethyl)-4-((4-chlorophenyl)(phenyl). Molecular formula: C25H31ClN2O6. Mole weight: 490.98. | |
| Levocetirizine Impurity 13 | Levocetirizine Impurity 13 is one of Levocetirizine impurities. Levocetirizine is an antihistamine used routinely for the treatment of various allergic disorders such as urticaria, eczemas, and also in itchy lesions of skin like scabies. Molecular formula: C23H29ClN2O4. Mole weight: 432.94. | |
| Levocetirizine Impurity 14 L-tartrate salt | Levocetirizine Impurity 14 L-tartrate salt is one of Levocetirizine impurities. Levocetirizine is an antihistamine used routinely for the treatment of various allergic disorders such as urticaria, eczemas, and also in itchy lesions of skin like scabies. Synonyms: (-)-Alpha-(4-Chlorophenyl)benzylamine(+)-tartrate salt. Grades: 98%. CAS No. 1159295-40-5. Molecular formula: C17H18ClNO6. Mole weight: 367.78. | |
| Levocetirizine Impurity 2 | Cas No. 300543-56-0. | |
| Levocetirizine Impurity 3 | Cas No. 113740-61-7. | |
| Levocetirizine Impurity 4 | Synonyms: (RS)-2-[2-[4-[(2-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid. Grades: > 95%. Molecular formula: C21H25ClN2O3. Mole weight: 388.90. | |
| Levocetirizine Impurity 5 | Cas No. 682323-77-9. | |
| Levocetirizine Impurity 6 | used in the synthesis of antifungal triazole and imidazole derivatives. Impurity of a intermediate in the formation of Cetrizine. Synonyms: 2-[4-[(RS)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol. Grades: > 95%. CAS No. 109806-71-5. Molecular formula: C19H23ClN2O. Mole weight: 330.86. | |
| Levocetirizine Impurity 7 | N,N-Bis(2-chloroethyl)benzenesulfonamide is a novel intermediate in the synthesis of Cetirizine. Synonyms: NSC 240403. Grades: > 95%. CAS No. 58023-19-1. Molecular formula: C10H13ClNO2S. Mole weight: 282.19. | |
| Levocetirizine Impurity 8 | 1-[(4-Chlorophenyl)phenylmethyl]-4-(phenylsulfonyl)piperazine is an impurity of Cetirizine. Synonyms: 1-(p-Chloro-α-phenylbenzyl)-4-(phenylsulfonyl)piperazine. Grades: > 95%. CAS No. 1391052-52-0. Molecular formula: C23H23ClN2O2S. Mole weight: 426.97. | |
| Levocetirizine Impurity 9 | Cetirizine impurity. Synonyms: (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetamide; 2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetamide. Grades: > 95%. CAS No. 83881-37-2. Molecular formula: C21H26ClN3O2. Mole weight: 387.91. | |
| Levocetirizine Lactose Ester Impurity | Levocetirizine Lactose Ester Impurity is one of Levocetirizine impurities. Levocetirizine is an antihistamine used routinely for the treatment of various allergic disorders such as urticaria, eczemas, and also in itchy lesions of skin like scabies. Molecular formula: C33H45ClN2O13. Mole weight: 713.17. | |
| Levocetirizine N-Oxide | N-Oxide Impurity of Levocetirizine. Synonyms: 2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-oxido-piperazin-1-yl]ethoxy] acetic acid. Grades: > 95%. Molecular formula: C21H25ClN2O4. Mole weight: 404.90. | |
| (R)-Cetirizine diHCl (Levocetirizine diHCl) | . Uses: Histamine h1 antagonists, non-sedating. Synonyms: (-)-Cetirizine dihydrochloride; 2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride, Levocetirizine dihydrochloride. Grades: >98%. CAS No. 130018-87-0. Molecular formula: C21H27Cl3N2O3. Mole weight: 388.90 2 36.46. | |
| (S)-Cetirizine DiHCl (Levocetirizine S-Isomer DiHCl) | A nonsedating type histamine H1-receptor antagonist. A major metabolite of Hydroxyzine. Pharmacological activity resides primarily in the (R)-isomer. Antihystaminic. Synonyms: (S)-[2-[4-[(4-Chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid Dihydrochloride; (+)-Cetirizine Dihydrochloride; Dextrocetirizine Dihydrochloride. Grades: > 95%. CAS No. 163837-48-7. Molecular formula: C21H25ClN2O3. 2 HCl. Mole weight: 388.90 2 36.46. | |
| 1-Benzylaziridin-2-one | Intermediate of Levocetirizine. Grades: > 95%. Molecular formula: C9H9NO. Mole weight: 147.18. | |
| [2-[4-[4-chlorophenylmethyl]-1-piperazinyl]-ethoxy]acetamide | Intermediate of Levocetirizine. Grades: > 95%. Molecular formula: C15H22ClN3O2. Mole weight: 311.81. | |
| 4-Chlorobenzhydrylamine hydrochloride | Intermediate of Levocetirizine. Synonyms: (4-chlorophenyl)-phenylmethanamine;hydrochloride. Grades: > 95 %. CAS No. 5267-39-0. Molecular formula: C13H13Cl2N. Mole weight: 254.16. | |
| Cetirizine EP Impurity B Dihydrochloride | Cetirizine EP Impurity B Dihydrochloride is an impurity of Cetirizine, a second-generation antihistamine used to treat allergic rhinitis, dermatitis, and urticaria. Synonyms: 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineacetic Acid Dihydrochloride; De(carboxymethoxy)Cetirizine Acetic Acid Dihydrochloride; Levocetirizine Impurity 3 DiHCl. Grades: 98%. CAS No. 1000690-91-4. Molecular formula: C19H23Cl3N2O2. Mole weight: 417.76. | |
| N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide | An impurity of Levocetirizine. Synonyms: 2-[2-[(2-Hydroxyethyl)amino]ethoxy]-N-(phenylmethyl)acetamide. Grades: > 95%. CAS No. 1391053-09-0. Molecular formula: C13H20N2O3. Mole weight: 252.32. | |
| N-Benzyl-2-chloro-N(chloroacetyl)acetamide | Intermediate of Levocetirizine. Grades: > 95%. Molecular formula: C11H11Cl2NO2. Mole weight: 260.12. | |
| N-Benzyl-N-[2-(benzylamino)-2-oxoethyl]-2-chloroacetamide | N-Benzyl-N-[2-(benzylamino)-2-oxoethyl]-2-chloroacetamide is one of Levocetirizine impurities. Levocetirizine is a third-generation antihistamine, an H1 receptor antagonist used in the treatment of allergic diseases. Synonyms: N-Benzyl-2-[(N-benzyl-N-chloroacetyl)amino]acetamide; 2-Chloro-N-[2-oxo-2-[(phenylmethyl)amino]ethyl]-N-(phenylmethyl)acetamide. Grades: 98%. CAS No. 1391051-79-8. Molecular formula: C18H19ClN2O2. Mole weight: 330.81. | |
| N,N'-Dibenzylglycinamide | N,N'-Dibenzylglycinamide impurity is one of Levocetirizine impurities. Levocetirizine is an antihistamine used routinely for the treatment of various allergic disorders such as urticaria, eczemas, and also in itchy lesions of skin like scabies. Synonyms: N-(Phenylmethyl)-2-[(phenylmethyl)amino]acetamide. Grades: > 95%. CAS No. 1089-31-2. Molecular formula: C16H18N2O. Mole weight: 254.33. | |
| (R)-Cetirizine Dihydrochloride | A nonsedating type histamine H1-receptor antagonist. A major metabolite of Hydroxyzine. Pharmacological activity resides primarily in the (R)-isomer. Antihystaminic. Group: Biochemicals. Alternative Names: 2- [2- [4- [ (R) - (4-Chlorophenyl) phenylmethyl] -1-piperazinyl] ethoxy] acetic Acid Dihydrochloride; (-)-Cetirizine Dihydrochloride; Levocetirizine Dihydrochloride. Grades: Highly Purified. CAS No. 130018-77-8. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
